Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Conditions:   Covid19;   Corona Virus Infection Interventions:   Diagnostic Test: Biochemistry blood test;   Diagnostic Test: Hematology blood test;   Diagnostic Test: D-Dimer test (coagulation);   Diagnostic Test: Inflammatory markers;   Diagnostic Test: Vital signs;   Diagnostic Test: VAS scale;   Diagnostic Test: WHO Ordinal  Score;   Diagnostic Test: COVID-19-Related Symptoms assessment;   Diagnostic Test: COVID-19-Impact on Quality-of-Life Questionnaire;   Diagnostic Test: POST- COVID-19 Functional Status Scale:;   Diagnostic Test: Pregnancy test;   Diagnostic Test: Physical examination;   Diagnostic Test:  PK parameters;   Diagnostic Test: SARS-CoV-2 test (PCR);   Diagnostic Test: ECG;   Drug: Treatment administration (twice a day) Sponsor:   MGC Pharmaceuticals d.o.o Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials